NEW YORK (Reuters Health) – Surgically induced weight loss is cost-effective relative to conventional therapy for the management of type 2 diabetes in obese patients, both in the…
NEW YORK (Reuters Health) For patients with epidermal growth factor (EGF) receptor-positive colorectal cancer and unresectable metastases, adding cetuximab to first-line treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)…
NEW YORK (Reuters Health) – Long-term treatment with infliximab has a good safety profile and significantly reduces hospitalization and surgery rates in patients with Crohn’s disease, according to…
NEW YORK (Reuters Health) – In patients with chronic hepatitis C genotype 4, adding nitazoxanide to peginterferon alfa-2a and ribavirin improves the virologic response rates, new research shows.…
NEW YORK (Reuters Health) – As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and –negative patients, according…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology, Northwestern University, discusses the management of patients in acute liver failure. References and Resources O’Neal H, Olds J, Webster N.…
NEW YORK (Reuters Health) – Patients who are admitted on a weekend for bleeding peptic ulcers have worse survival than their peers admitted on a weekday, according to…
NEW YORK (Reuters Health) – Consuming seven glasses or more of wine each week may reduce the risk of developing Barrett’s esophagus, according to a report in the…
NEW YORK (Reuters Health) – In premenopausal women with endocrine-responsive early breast cancer, addition of the bisphosphonate zoledronic acid to endocrine therapy significantly improves disease-free survival, physicians in…
By Will Boggs, MD NEW YORK (Reuters Health) – Morbidly obese patients face higher complication rates than do normal-weight patients after undergoing surgery for colon cancer, according to…